Engrailed-1 Promotes Pancreatic Cancer Metastasis

© 2023 The Authors. Advanced Science published by Wiley-VCH GmbH..

Engrailed-1 (EN1) is a critical homeodomain transcription factor (TF) required for neuronal survival, and EN1 expression has been shown to promote aggressive forms of triple negative breast cancer. Here, it is reported that EN1 is aberrantly expressed in a subset of pancreatic ductal adenocarcinoma (PDA) patients with poor outcomes. EN1 predominantly repressed its target genes through direct binding to gene enhancers and promoters, implicating roles in the activation of MAPK pathways and the acquisition of mesenchymal cell properties. Gain- and loss-of-function experiments demonstrated that EN1 promoted PDA transformation and metastasis in vitro and in vivo. The findings nominate the targeting of EN1 and downstream pathways in aggressive PDA.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Advanced science (Weinheim, Baden-Wurttemberg, Germany) - 11(2024), 6 vom: 19. Feb., Seite e2308537

Sprache:

Englisch

Beteiligte Personen:

Xu, Jihao [VerfasserIn]
Roe, Jae-Seok [VerfasserIn]
Lee, EunJung [VerfasserIn]
Tonelli, Claudia [VerfasserIn]
Ji, Keely Y [VerfasserIn]
Younis, Omar W [VerfasserIn]
Somervile, Tim D D [VerfasserIn]
Yao, Melissa [VerfasserIn]
Milazzo, Joseph P [VerfasserIn]
Tiriac, Herve [VerfasserIn]
Kolarzyk, Anna M [VerfasserIn]
Lee, Esak [VerfasserIn]
Grem, Jean L [VerfasserIn]
Lazenby, Audrey J [VerfasserIn]
Grunkemeyer, James A [VerfasserIn]
Hollingsworth, Michael A [VerfasserIn]
Grandgenett, Paul M [VerfasserIn]
Borowsky, Alexander D [VerfasserIn]
Park, Youngkyu [VerfasserIn]
Vakoc, Christopher R [VerfasserIn]
Tuveson, David A [VerfasserIn]
Hwang, Chang-Il [VerfasserIn]

Links:

Volltext

Themen:

Apoptosis
Cancer progression
Cancer therapeutics
Developmental transcription factor
ERK signaling
Engrailed-1
Epigenetic reprogramming
Journal Article
Metastasis
Pancreatic ductal adenocarcinoma
Transcription Factors

Anmerkungen:

Date Completed 14.02.2024

Date Revised 12.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/advs.202308537

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM366015370